Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

Trial Profile

Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Nimodipine (Primary) ; Nimodipine (Primary)
  • Indications Aneurysm; Subarachnoid haemorrhage
  • Focus Adverse reactions
  • Sponsors Edge Therapeutics
  • Most Recent Events

    • 13 Mar 2017 According to an Edge Therapeutics media release, first patient has been randomized in this trial. Nerissa U. Ko is investigator of this study. Company expects data from this study in 2017.
    • 09 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 01 Nov 2016 According to an Edge Therapeutics media release, this trial is expected to initiate patient enrollment in the fourth quarter of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top